Item 8.01. Other Events.

On December 2, 2019, New Frontier Corporation (the "Company") issued a press release announcing that it will hold its extraordinary general meeting (the "Extraordinary General Meeting") relating to the previously announced Business Combination (the "Business Combination") with United Family Healthcare ("UFH") on Thursday, December 12, 2019 at 9:00 a.m. Eastern Time at the offices of Winston & Strawn LLP, located at 200 Park Avenue, New York, New York.

Shareholders of record as of the close of business on November 19, 2019 (the "Record Date") will be entitled to receive notice of and to vote at the Extraordinary General Meeting. In connection with the Extraordinary General Meeting, the Company's shareholders who wish to exercise their redemption rights must do so no later than 5:00 p.m. Eastern Time on December 10, 2019 by following the procedures specified in the definitive proxy statement for the Extraordinary General Meeting.

A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

Important Information About the Business Combination and Where to Find It

In connection with the proposed Business Combination, the Company filed a definitive proxy statement (the "Proxy Statement") with the U.S. Securities and Exchange Commission (the "SEC"). The Company will mail the definitive proxy statement and other relevant documents to its shareholders of record as of the Record Date. The Company's shareholders and other interested persons are advised to read the definitive proxy statement as it contains important information about the Company, UFH and the Business Combination. Shareholders may obtain copies of the definitive proxy statement and other documents filed with the SEC, without charge, at the SEC's web site at www.sec.gov, or by directing a request to: New Frontier Corporation, 23rd Floor, 299 QRC 287-299, Queen's Road Central, Hong Kong, Attention: Harry Chang, or by telephone at (852) 3703-3251.

Participants in the Solicitation

The Company and UFH and their respective directors and executive officers may be deemed participants in the solicitation of proxies from the Company's shareholders with respect to the Business Combination. A list of the names of those directors and executive officers and a description of their interests in the Company, UFH and the Business Combination is contained in the definitive proxy statement for the Business Combination, which was filed with the SEC on November 27, 2019 and is available free of charge at the SEC's web site at www.sec.gov, or by directing a request to: New Frontier Corporation, 23rd Floor, 299 QRC 287-299, Queen's Road Central, Hong Kong, Attention: Harry Chang, or by telephone at (852) 3703-3251.

Information Concerning Forward-Looking Statements

The Company makes forward-looking statements in this report within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to expectations or forecasts for future events. These statements may be preceded by, followed by or include the words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "should," "future," "propose" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company's or UFH's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. These forward-looking statements include, without limitation, the Company's and UFH's expectations with respect to the timing of the Extraordinary Meeting, the satisfaction of the closing conditions of the Business Combination and the timing of the completion of the Business Combination. Important factors, among others, that may affect actual results or outcomes include the inability to complete the Business Combination (including due to the failure to receive required shareholder approvals, or the failure of other closing conditions); the inability to recognize the anticipated benefits of the proposed Business Combination; the inability to meet the listing requirements of the New York Stock Exchange; costs related to the Business Combination; UFH's ability to manage growth; UFH's ability to execute its business plan and meet its projections; UFH's ability to identify, consummate and integrate acquisitions; rising costs adversely affecting UFH's profitability; potential litigation involving the Company or UFH, or after the closing, the post-business combination company; general economic and market conditions impacting demand for UFH's services, and in particular economic and market conditions in the Chinese healthcare industry and changes in the rules and regulations that apply to such business, including as it relates to foreign investments in such businesses; and such other risks and uncertainties as are discussed in the definitive proxy statement relating to the Business Combination, including those under "Risk Factors" therein, and in the Company's other filings with the SEC. None of the Company or UFH undertakes any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.











No Offer or Solicitation

This Current Report on Form 8-K shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the Business Combination. This Current Report on Form 8-K shall also not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of section 10 of the Securities Act.

Item 9.01 Financial Statements and Exhibits.





 (d) Exhibits.




Exhibit No.                  Description
  99.1          Press Release, dated December 2, 2019.

© Edgar Online, source Glimpses